Caxton Associates LP
- SEC CIK
- 0000872573
- Latest filing
- Feb 14, 2025
INO holding history
Inovio Pharmaceuticals, Inc. in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INO overviewAll 13F holders of INOFull Q4 2024 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −784,679−100.0% | Sold out | Holders |
| Q1 2023 | 784,679 | $643.4K | 0.1% | +201,512+34.6% | Added | Holders |
| Q4 2022 | 583,167 | $909.7K | 0.1% | +452,439+346.1% | Added | Holders |
| Q3 2022 | 130,728 | $226.0K | <0.1% | +130,728 | New | Holders |